Francesco Mazziotta

Dr. Francesco Mazziotta is an Acting Instructor in the Division of Hematology and Oncology at the University of Washington School of Medicine, with primary research and clinical activities at the Fred Hutchinson Cancer Center in Seattle, Washington. His work bridges translational research and clinical practice, focusing on hematologic malignancies and immunotherapy approaches.

Dr. Mazziotta received his M.D. from the University of Pisa, Italy, and his Ph.D. from the University of Siena, Italy. He completed his residency and fellowship in Hematology/Oncology at the University of Pisa.

His research focuses on understanding immune dysfunction in acute myeloid leukemia and other hematologic malignancies, integrating experimental models and computational tools to investigate mechanisms of therapy resistance. Dr. Mazziotta specializes in adoptive cell therapy, including chimeric antigen receptor (CAR) T cells, TCR-engineered T cells, and tumor-infiltrating lymphocytes (TILs), with work spanning both hematologic and solid tumors.

Analysis of Dr. Mazziotta's recent publications reveals a strong focus on acute myeloid leukemia, particularly exploring immune dysfunction mechanisms, T-cell differentiation patterns, and novel therapeutic approaches including immunotherapy and cell-based treatments. His work often involves collaborations with the Fred Hutchinson Cancer Research Center and University of Washington teams, with significant contributions to understanding minimal residual disease, biomarker development, and treatment resistance mechanisms.

Dr. Mazziotta has made significant contributions across multiple areas of hematology and oncology research, with publications spanning basic science, translational research, and clinical applications. His work demonstrates expertise in both laboratory-based investigations and clinical trial design and analysis.